Revvity Inc (RVTY)
114.91
-1.14
(-0.98%)
USD |
NYSE |
Nov 15, 09:49
Revvity Free Cash Flow: 564.37M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 564.37M |
| June 30, 2024 | 382.96M |
| March 31, 2024 | 97.11M |
| December 31, 2023 | 9.904M |
| September 30, 2023 | -49.56M |
| June 30, 2023 | 153.20M |
| March 31, 2023 | 380.45M |
| December 31, 2022 | 594.18M |
| September 30, 2022 | 789.79M |
| June 30, 2022 | 932.27M |
| March 31, 2022 | 1.122B |
| December 31, 2021 | 1.325B |
| September 30, 2021 | 1.492B |
| June 30, 2021 | 1.394B |
| March 31, 2021 | 1.248B |
| December 31, 2020 | 828.54M |
| September 30, 2020 | 544.65M |
| June 30, 2020 | 443.56M |
| March 31, 2020 | 351.89M |
| December 31, 2019 | 282.14M |
| September 30, 2019 | 216.78M |
| June 30, 2019 | 199.05M |
| March 31, 2019 | 224.80M |
| December 31, 2018 | 217.78M |
| September 30, 2018 | 202.54M |
| Date | Value |
|---|---|
| June 30, 2018 | 177.80M |
| March 31, 2018 | 164.40M |
| December 31, 2017 | 249.36M |
| September 30, 2017 | 279.43M |
| June 30, 2017 | 296.88M |
| March 31, 2017 | 342.29M |
| December 31, 2016 | 318.91M |
| September 30, 2016 | 292.32M |
| June 30, 2016 | 280.25M |
| March 31, 2016 | 250.08M |
| December 31, 2015 | 258.88M |
| September 30, 2015 | 235.67M |
| June 30, 2015 | 237.82M |
| March 31, 2015 | 225.94M |
| December 31, 2014 | 254.44M |
| September 30, 2014 | 227.10M |
| June 30, 2014 | 211.33M |
| March 31, 2014 | 182.20M |
| December 31, 2013 | 119.61M |
| September 30, 2013 | 76.81M |
| June 30, 2013 | 45.23M |
| March 31, 2013 | 98.56M |
| December 31, 2012 | 109.77M |
| September 30, 2012 | 165.21M |
| June 30, 2012 | 196.18M |
Free Cash Flow Range, Past 5 Years
-49.56M
Minimum
Sep 2023
1.492B
Maximum
Sep 2021
644.29M
Average
554.51M
Median
Free Cash Flow Benchmarks
| Bionano Genomics Inc | -106.10M |
| Avantor Inc | 747.20M |
| Bruker Corp | 156.70M |
| Azenta Inc | 40.93M |
| Harvard Bioscience Inc | 0.16M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 147.88M |
| Cash from Investing (Quarterly) | 690.18M |
| Cash from Financing (Quarterly) | -873.74M |
| Free Cash Flow Per Share (Quarterly) | 1.021 |
| Free Cash Flow to Equity (Quarterly) | 812.84M |
| Free Cash Flow to Firm (Quarterly) | 127.07M |
| Free Cash Flow Yield | 3.98% |